New Technologies for HPAPI Manufacturing and Containment

HPAPI USA 2019
Focus on new technology at the 2019 HPAPI USA Conference
LONDON, UNITED KINGDOM, August 29, 2019 /EINPresswire.com/ -- SMI Reports: With new technologies becoming available for the pharmaceutical industry, the HPAPI market is utilising these new innovations to simplify manufacturing processes reducing powder exposure and allowing a semi-continuous production.At this year's HPAPI USA Conference emerging manufacturing technologies will be one of the key points to be discussed along with containment issues, disaster management, Oncology Antibody-Drug Conjugates (ADCs) and staff training procedures.
Key highlights include:
Alternative HPAPI manufacturing technologies to reduce powder exposure and improving safety along with enabling continuous manufacturing
- Alternative drug manufacture through nanocrystal formulations, thin films and hot-melt extrusion/injection moulding that reduces HPAPI powder exposure and improve safety
- Detailing step-by-step process along with the equipment needed to achieve these alternative HPAPI manufacturing techniques
- The advantages of continuous manufacturing utilizing alternative manufacturing technologies
Respiratory HPAPIs: development, formulation and delivery
- Advantages and targets of a respiratory HPAPI
- Equipment and analytical instruments that are most suitable for respiratory containment and safe handling
- Strategies for the development and industrialization process to ensure respiratory HPAPI success
- The current trends in respiratory HPAPIs
Training and managing workers with HPAPI exposure, along with the best available techniques for cleaning and waste management
- Staff training - understanding the equipment they are using
- Due diligence for management to continually assess the HPAPI workspace and keeping operators up to date
- Understand the need to establish expectations surrounding the safe handling of HPAPI
www.hpapi-usa.com/PR5
Sponsored by BSP Pharmaceuticals | LONZA | Minakem | SafeBridge Consultants
Highly Potent Active Pharmaceutical Ingredients USA
Conference: October 21st – 22nd
Workshops: October 23rd
Venue: Sheraton Boston Hotel, USA
For delegate enquiries, please contact Fateja Begum on +44 (0)20 7827 6184 or fbegum@smi-online.co.uk
For sponsorship, exhibition and branding enquiries, please contact Alia Malick on +44 (0)20 7827 6168 or amalick@smi-online.co.uk
For media enquiries contact Neill Howard on Tel: +44 (0)20 7827 6164 or nhoward@smi-online.co.uk
Neill Howard
SMi Group Ltd
+44 20 7827 6000
email us here
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.